Hemlibra in Mild Hemophilia A — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hemlibra in Mild Hemophilia A — Stella

Recruiting

Back to Factor VIII Deficiency, Congenital trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana

Key details

Phase

Post-approval study

Sponsor

Indiana Hemophilia &Thrombosis Center, Inc.

Collaborators

Genentech, Inc.

Enrollment target

~20 participants

Started

July 2022

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

5 Years – 45 Years

Sex

Male only

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov